Clonidine Hydrochloride Tablet, Extended Release
Product Images NDC 68001-568

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clonidine Hydrochloride (NDC 68001-568). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clonidine HCl Er Tablets 0.1 mg (Clonidine 0 1mg)

Clonidine HCl Er Tablets 0.1 mg (Clonidine 0 1mg)
Label for Clonidine Hydrochloride Extended-Release Tablets, 0.1 mg, by BluePoint Laboratories. The label includes dosing, storage instructions, and states the product contains 60 extended-release tablets. Manufactured by Ajanta Pharma Limited in India. The label also features the product NDC 68001-568.*
FDA Label Image

Clonidine_structure (Clonidine)

Clonidine_structure (Clonidine)
Chemical structure of clonidine hydrochloride, showing a bicyclic heteroaromatic compound with two chlorine atoms and a hydrochloride salt represented alongside.*
FDA Label Image

Figure1 (Clonidine Figure1)

Figure1 (Clonidine Figure1)
A line graph showing mean plasma concentration of Clonidine Hydrochloride over 48 hours. It compares extended-release formulation under fasted and fed conditions and immediate-release formulation under fasted condition. Concentration (pg/mL) is plotted against time (hours), illustrating different pharmacokinetic profiles for each formulation and condition.*
FDA Label Image

Figure02 (Clonidine Figure2)

Figure02 (Clonidine Figure2)
A Kaplan-Meier survival curve graph showing estimated proportions of patients at treatment failure over days from randomization. The graph compares Clonidine hydrochloride extended-release tablets to placebo, with the horizontal axis representing days and the vertical axis representing treatment failure proportion. Censored data points are marked.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.